Demand for RNA Therapy Clinical Trials in UK

Table of Content

1. Executive Summary
   • UK Market Outlook
   • Demand to side Trends
   • Supply to side Trends
   • Technology Roadmap Analysis
   • Analysis and Recommendations
2. Market Overview
   • Market Coverage / Taxonomy
   • Market Definition / Scope / Limitations
3. Market Background
   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunity
     • Trends
   • Scenario Forecast
     • Demand in Optimistic Scenario
     • Demand in Likely Scenario
     • Demand in Conservative Scenario
   • Opportunity Map Analysis
   • Product Life Cycle Analysis
   • Supply Chain Analysis
   • Investment Feasibility Matrix
   • Value Chain Analysis
   • PESTLE and Porter’s Analysis
   • Regulatory Landscape
   • Regional Parent Market Outlook
   • Production and Consumption Statistics
   • Import and Export Statistics
4. UK Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
   • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
   • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
     • Y to o to Y Growth Trend Analysis
     • Absolute $ Opportunity Analysis
5. UK Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
6. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Therapeutic Area
   • Introduction / Key Findings
   • Historical Market Size Value (USD Million) Analysis By Therapeutic Area, 2021 to 2025
   • Current and Future Market Size Value (USD Million) Analysis and Forecast By Therapeutic Area, 2026 to 2036
     • Rare Diseases
     • Anti-infective
     • Anticancer
     • Neurological
     • Others
   • Y to o to Y Growth Trend Analysis By Therapeutic Area, 2021 to 2025
   • Absolute $ Opportunity Analysis By Therapeutic Area, 2026 to 2036
7. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Modality
   • Introduction / Key Findings
   • Historical Market Size Value (USD Million) Analysis By Modality, 2021 to 2025
   • Current and Future Market Size Value (USD Million) Analysis and Forecast By Modality, 2026 to 2036
     • Messenger RNA
     • RNA Interference
     • Antisense Therapy
     • Oligonucleotide
   • Y to o to Y Growth Trend Analysis By Modality, 2021 to 2025
   • Absolute $ Opportunity Analysis By Modality, 2026 to 2036
8. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
   • Introduction
   • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
   • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
     • UK
   • Market Attractiveness Analysis By Region
9. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
   • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
   • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
     • By Country
     • By Therapeutic Area
     • By Modality
   • Market Attractiveness Analysis
     • By Country
     • By Therapeutic Area
     • By Modality
   • Key Takeaways
10. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Therapeutic Area
      • By Modality
11. Competition Analysis
    • Competition Deep Dive
      • IQVIA Holdings Inc.
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • ICON plc
      • Labcorp Holdings Inc.
      • Charles River Laboratories International Inc.
      • Parexel
      • Syneos Health
      • Medpace Holdings Inc.
      • Pharmaceutical Product Development (PPD)
      • Novotech Health Holdings Pte. Ltd.
      • Veristat LLC
12. Assumptions & Acronyms Used
13. Research Methodology